CORE-TIMI 72a and CORE2-TIMI 72b trials found that olezarsen significantly reduced triglyceride levels at 6 months, as well as decreased the incidence of acute pancreatitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results